Burden of benign prostatic hyperplasia in the Middle East and North Africa Region, 1990–2021

Burden of benign prostatic hyperplasia in the Middle East and North Africa Region, 1990–2021

Abstract Objective To examine the burden of benign prostatic hyperplasia (BPH) in the Middle East and North Africa (MENA) region from 1990 to 2021 by age and sociodemographic index (SDI). Methods Data were sourced from the Global Burden of Disease (GBD) 2021 database. We analysed the incidence, prev...

Full description

Saved in:

Bibliographic Details
Main Authors:	Saeid Safiri, Fikrettin Şahin, Reza Aletaha, Mark J. M. Sullman, Reza Shekarriz-Foumani, Ali-Asghar Kolahi
Format:	Article
Language:	English
Published:	BMC 2025-02-01
Series:	BMC Public Health
Subjects:	Benign prostatic hyperplasia Middle East and North Africa Global Burden of Disease Prevalence Incidence
Online Access:	https://doi.org/10.1186/s12889-025-21735-2
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The burden of prostate cancer in the North Africa and Middle East Region from 1990 to 2021
by: Saeid Safiri, et al.
Published: (2025-01-01)

Rauwolfia vomitoria- a promising medical plant for benign prostatic hyperplasia management; yet with challenges
by: George Awuku Asare, et al.
Published: (2025-02-01)

Burden and trends of dietary iron deficiency in the Middle East and North Africa region, 1990–2021
by: Saeid Safiri, et al.
Published: (2025-01-01)

IMPROVING THE QUALITY OF PROSTATE TRANSURETHRAL RESECTION IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA THROUGH INTRAOPERATIVE TRANSRECTAL ULTRASOUND MONITORING OF THE REMOVED TISSUE VOLUME
by: V. B. Filimonov, et al.
Published: (2019-06-01)

The effect of systemic hypertension on prostatic arterial hemodynamics in dogs with benign prostate hyperplasia
by: Çağatay ESİN
Published: (2024-11-01)

Exploring the association between caffeine intake and benign prostatic hyperplasia: results from the NHANES 2005–2008
by: Fei Zhang, et al.
Published: (2025-01-01)

Magnitude and factors associated with benign prostatic hyperplasia among adult male patients visiting Wolaita Sodo University comprehensive specialized hospital southern Ethiopia
by: Tirufat Tiruneh, et al.
Published: (2024-12-01)

Influence of chronic ischemic disorders in the prostate on the development of benign prostatic hyperplasia
by: G. E. Roitberg, et al.
Published: (2020-06-01)

Thulium laser enucleation of the prostate plus thulium fiber laser therapy for benign prostatic hyperplasia combined with bladder stones
by: Chen Wang, et al.
Published: (2024-08-01)

PHARMACOTHERAPY IN PATIENTS WITH ERECTILE DYSFUNCTION AND BENIGN PROSTATIC HYPERPLASIA IN THE ABSENCE OF RISK OF DISEASE PROGRESSION
by: A. A. Kamalov, et al.
Published: (2018-03-01)

A Systematic Review of Medical Treatments for Benign Prostatic Hyperplasia in Dogs: Evaluating Strategies for Reproductive Function Preservation
by: Florin Petrișor Posastiuc, et al.
Published: (2025-01-01)

Potential clinical application of the cancer antigen CA‑62 for differential diagnosis of prostate cancer and benign prostatic hyperplasia at the elevated prostate‑specific antigen
by: Zh. R. Cherkasova, et al.
Published: (2023-03-01)

Quantitative estimation of drugs for erectile dysfunction and benign prostatic hyperplasia by high performance liquid chromatography: a review
by: Shalaka G. Gaonkar, et al.
Published: (2024-12-01)

WATER versus WATER II 5‐year update: Comparing Aquablation therapy for benign prostatic hyperplasia in 30–80‐cm3 and 80–150‐cm3 prostates
by: Mohamad Baker Berjaoui, et al.
Published: (2024-11-01)

Associations among immunophenotype, plasma metabolites, and benign prostatic hyperplasia: a mediation Mendelian randomization study
by: FAN Jiuming, et al.
Published: (2025-01-01)

Alleviatory effect of isoquercetin on benign prostatic hyperplasia via IGF-1/PI3K/Akt/mTOR pathway
by: Young-Jin Choi, et al.
Published: (2024-05-01)

Epidemiology of urinary tract infections in the Middle East and North Africa, 1990–2021
by: Fatemeh Amiri, et al.
Published: (2025-02-01)

The Role of Immunohistochemistry for AMACR/p504s and p63 in Distinguishing Prostate Cancer from Benign Prostate Tissue Samples in Botswana
by: Ramatlho P, et al.
Published: (2025-01-01)

Comparison of Finasteride and Dutasteride on Risk of Prostate Cancer in Patients with Benign Prostatic Hyperplasia: A Pooled Analysis of 15 Real-world Databases
by: Dae Yul Yang, et al.
Published: (2025-01-01)

Monitoring of prostate-specific antigen in men with benign prostate enlargement receiving 5-alpha reductase inhibitors: a non-interventional, cross-sectional study of real-world practice of urologists in Spain and Brazil
by: Juan Manuel Palacios, et al.
Published: (2025-01-01)

Purple corn extract improves benign prostatic hyperplasia by inhibiting 5 alpha-reductase type 2 and inflammation in testosterone propionate-induced rats
by: Sung-Ok Kim, et al.
Published: (2025-01-01)

Burden of diseases attributable to excess body weight in 204 countries and territories, 1990–2019
by: Saeid Safiri, et al.
Published: (2025-02-01)

Prostatic Artery Embolization: A Systematic Review Article
by: Pooja Atkuri, et al.
Published: (2025-01-01)

Features of conservative therapy of benign prostatic hyperplasia in patients with metabolic syndrome: " Treat to Target "
by: V. B. Filimonov, et al.
Published: (2020-12-01)

Association between Chinese visceral adiposity index and lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH): a national cohort study
by: Kunhui Chang, et al.
Published: (2025-01-01)

Safety and feasibility of En‐bloc holmium laser enucleation for very large prostates (> 200 cc) with trainee involvement
by: Feres C. Maluf, et al.
Published: (2025-01-01)

Malondialdehyde in benign prostate hypertrophy: a useful marker?
by: Rosaria Alba Merendino, et al.
Published: (2003-01-01)

Application of mean maximum Young’s modulus value as a new parameter for differential diagnosis of prostate diseases
by: Nailei Huang, et al.
Published: (2025-01-01)

Urology pathways for the primary care physician
by: J John
Published: (2024-04-01)

Incidence of prostate adenocarcinoma in transurethral resection of the prostate patients
by: Yahia Ghazwani, et al.
Published: (2025-01-01)

Can handheld ultrasound probes reliably measure transabdominal prostate and bladder volumes? A prospective randomized point-of-care ultrasound study
by: Henry C. Wright, et al.
Published: (2025-02-01)

A comprehensive analysis of erectile dysfunction prevalence and the impact of prostate conditions on ED among US adults: evidence from NHANES 2001-2004
by: Yuhao Zhang, et al.
Published: (2025-01-01)

A comprehensive analysis of trends in the burden of gout in China and globally from 1990 to 2021
by: Shiwei Xie, et al.
Published: (2025-01-01)

Optimization of Wall-disruption Process of Rose Bee Pollen and Comparison of Physiological Activities of Its Ethanol Extracts
by: Xinyang LU, et al.
Published: (2025-02-01)

The significance of the immunohistochemical method in diagnosing atypical endometrial polyps as manifestations of localized hyperplasia
by: O.V. Poslavska, et al.
Published: (2024-12-01)

The global, regional burden of pancreatic cancer and its attributable risk factors from 1990 to 2021
by: Weidong Yu, et al.
Published: (2025-01-01)

Spinal CRH facilitates the micturition reflex via the CRH2 receptor in rats with normal bladder and bladder outlet obstruction
by: Risa Shinoki, et al.
Published: (2025-01-01)

Asthma-associated prostate enlargement and bladder smooth muscle hypercontractility: unveiling a potential link to LUTS
by: Peibin Cen, et al.
Published: (2025-01-01)

A comprehensive analysis and comparative study of the trends in thyroid cancer burden in China and globally from 1990 to 2021, with projections for the next 15 Years
by: Yulai Yin, et al.
Published: (2025-02-01)

Global burden of breast cancer and attributable risk factors in 204 countries and territories, from 1990 to 2021: results from the Global Burden of Disease Study 2021
by: Rui Sha, et al.
Published: (2024-08-01)